Agenda
The Nontuberculous Mycobacteria Conference will be held May 27-30, 2025 at Colorado State University.
Tuesday May 27, 2025 (5-9 p.m.)
| Time | Title & Speaker |
|---|---|
| 5 p.m. | Registration opens. |
| 5-6:30 p.m. | Cocktails & Appetizers |
| 6:30-6:40 p.m. | Welcome Address Mary Jackson – Colorado State University |
| 6:40-7:15 p.m. | Keynote: NTM reflections – what have patients taught us? Rachel Thomson – The University of Queensland, Australia |
| 7:15-7:40 p.m. | Break |
| 7:40-8:15 p.m. | Keynote: NTM reflections – what has science taught us? Kenneth N. Olivier – University of North Carolina School of Medicine |
Wednesday May 28, 2025
| Time | Title & Speaker |
|---|---|
| Session 1: Epidemiology and Clinical Aspects of NTM Pulmonary Disease Discussion leader: Charles L. Daley – National Jewish Health |
|
| 8-8:05 a.m. | Introduction |
| 8:05-8:25 a.m. | The Power of Patient Preferences. Amy Leitman – NTMir Inc. |
| 8:30-8:50 a.m. | Epidemiology of NTM: Current trends in USA and globally. Ettie Lipner – National Institute of Allergy and Infectious Diseases |
| 8:50-9:10 a.m. | Mycobacterium chelonae outbreak in a Pediatric Hospital: Genomic investigation linked to environmental water biofilms Jane E. Gross – University of North Carolina |
| 9:10-9:30 a.m. | From source to tap: Nontuberculous mycobacteria in a full-scale drinking water system Katherine S. Dowdell – University of Texas at Austin |
| 9:30-10 a.m. | Coffee Break |
| 10-10:20 a.m. | Microbiological biomarkers of human exposure to mycobacteria: Can we go bigger? Gerard A. Cangelosi – University of Washington |
| 10:20-10:40 a.m. | Talk selected from abstracts |
| 10:40-11 a.m. | MACaque: a non-human primate model of Pulmonary MAC Kevin Winthrop – Oregon Health and Science University |
| 11-11:20 a.m. | Talk selected from abstracts. |
| 11:20-11:40 a.m. | Talk selected from abstracts. |
| 12-1:30 p.m. | Lunch (Ram’s Horn Dining Center) |
| Session 2: Diagnostics, Biomarkers and Vaccines Discussion leader: Jerry A. Nick – National Jewish Health |
|
| 1:30-1:50 p.m. | Detection, Diagnosis and Duration: Future Markers of NTM Infection Jerry A. Nick – National Jewish Health |
| 1:50-2:10 p.m. | Novel RNA Vaccines for Non-Tuberculous Mycobacterium Adel Talaat – University of Wisconsin |
| 2:10-2:30 p.m. | Next Generation Sequencing and Laboratory-Developed Tests: A New Era in NTM Identification Kimberlee A. Musser – New York State Department of Health |
| 2:30-2:50 p.m. | Observations on mycobacterial lung infections via exhaled breath molecules. Jane E. Hill – University of British Columbia, Canada |
| 2:50-3:10 p.m. | Talk selected from abstracts. |
| 3:10-3:30 p.m. | Talk selected from abstracts. |
| 3:30-5:30 p.m. | Poster Session & Light Appetizers |
Thursday May 29, 2025
| Time | Title & Speaker |
|---|---|
| Session 3: Pathogenic strategies of NTM and host immune response to NTM infections Discussion leaders: Marcela Henao-Tamayo – Colorado State University and Laurent Kremer – Institut de Recherche en Infectiologie de Montpellier, France |
|
| 8-8:20 a.m. | Introduction |
| 8:20-8:45 a.m. | NTMs and mycobacteriophages: The good, the bad, and the ugly. Graham F. Hatfull – University of Pittsburgh |
| 8:45-9:05 a.m. | Exploring Virulence Factors and Parietal Lipids in Mycobacterium abscessus: Potential Biomarkers for Diagnosis. Jean-Louis Herrmann – Université Paris-Saclay, France |
| 9:05-9:25 a.m. | Mycobacterium abscessus learns new tricks: how acquisition of toxin-antitoxin systems contributes to antibiotic resistance. Nancy A. Woychik – Rutgers University |
| 9:30-10 a.m. | Coffee Break |
| 10-10:20 a.m. | Talk selected from abstracts. |
| 10:20-10:40 a.m. | Talk selected from abstracts. |
| 10:40-11 a.m. | Talk selected from abstracts. |
| 11-11:20 a.m. | Talk selected from abstracts. |
| 11:30 a.m. -1:30 p.m. | Lunch (Ram’s Horn Dining Center) |
| Session 4: Genetics and Physiology of NTM Discussion leader: Anil K. Ojha-New York State Department of Health, Wadsworth Center |
|
| 1:30-1:50 p.m. | Insights into NTM physiology: searching for new therapeutic approaches. Anil K. Ojha – New York State Department of Health, Wadsworth Center |
| 1:50-2:10 p.m. | Measurement and prediction of chemical permeability in M. abscessus. Mark R. Sullivan – Harvard School of Public Health |
| 2:10-2:30 p.m. | Exploiting distributive conjugal transfer in M. smegmatis to determine how mycobacteria recognize and respond to each other. Keith M. Derbyshire – New York State Department of Health |
| 2:30-2:50 p.m. | Talk selected from abstracts. |
| 2:50-3:10 p.m. | Talk selected from abstracts. |
| 3:10-3:30 p.m. | Talk selected from abstracts. |
| 3:30-5:30 p.m. | Poster Session |
| 6-7 p.m. | Happy Hour (CS Stadium) |
| 7-10 p.m. | Gala Dinner (CSU Stadium) |
Friday May 30, 2025
| Time | Title & Speaker |
|---|---|
| Session 5: Therapeutic Strategies and Clinical Trials Discussion leader: Thomas Dick – Hackensack Meridian Health |
|
| 8-8:20 a.m. | NTM Clinical Pipeline Charles L. Daley – National Jewish Health |
| 8:20-8:40 a.m. | NTM Preclinical Pipeline Richard E. Lee – St Jude Children’s Research Hospital |
| 8:40-8:50 a.m. | Discussion |
| 8:50-9:10 a.m. | Development of a next-generation rifamycin antibiotic for treating NTM that overcomes intrinsic resistance and does not induce cytochrome P450s. Courtney C. Aldrich – University of Minnesota |
| 9:10-9:25 a.m. | Profiling of β-lactam selectivity for penicillin-binding proteins in Mycobacterium avium complex. Alaa Ropy Sayed – University of Florida |
| 9:25-9:40 a.m. | A Game-Changer in Fighting Mycobacterium abscessus: A Multidisciplinary Approach to β-Lactam Combination Therapy. Eunjeong Shin – Case Western Reserve University |
| 9:45-10:15 a.m. | Coffee Break |
| 10:15-10:35 a.m. | Leveraging TB drug pipeline toward NTM drug discovery and regimen development. Natalya Serbina – TB Alliance |
| 10:35-10:55 a.m. | Talk selected from abstracts. |
| 10:55-11:15 a.m. | A Randomized Trial for Mycobacterium abscessus pulmonary disease- the FORMaT study Rachel Thomson – The University of Queensland, Australia |
| 11:15-11:35 a.m. | Talk selected from abstracts. |
| 11:35-11:55 a.m. | Talk selected from abstracts. |
| 12-1:20 p.m. | Lunch (Ram’s Horn Dining Center) |
| 1:20-1:35 p.m. | Poster Awards |
| Session 6: Therapeutic Strategies: Platforms and Tools Discussion leaders: Kenneth N. Olivier – University of North Carolina School of Medicine and Mary Jackson – Colorado State University |
|
| 1:35-1:55 p.m. | Characterization of Mouse Models of NTM infection for screening of antimicrobial drugs. Mercedes Gonzalez-Juarrero – Colorado State University |
| 1:55-2:10 p.m. | Evaluating respiratory function in mouse models of NTM pulmonary infection. Camron Pearce – Colorado State University |
| 2:10-2:25 p.m. | Modeling NTM infection using air-liquid interface culture. Mark R. Sullivan – Harvard School of Public Health |
| 2:30 p.m. | Meeting ends. |